Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mei Pharma Inc (NQ: MEIP )

2.800 +0.020 (+0.72%)
Streaming Delayed Price Updated: 12:29 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mei Pharma Inc

< Previous 1 2 3 4 5 6 7 Next >
Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket
Gainers Pacifico Acquisition Corp. (NASDAQ: PAFO) shares rose 40.9% to $7.58 in pre-market trading after dipping around 43% on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin’s Lymphoma in Japan
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Reports First Quarter Fiscal Year 2023 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma and Kyowa Kirin Announce Acceptance of Three Abstracts for Presentation at the American Society of Hematology Annual Meeting 2022
From MEI Pharma, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning! 
Via InvestorPlace
Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
Why Snap Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 40.9% to $0.2160 in pre-market trading. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them! 
Via InvestorPlace
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Announces Changes to Board of Directors
From MEI Pharma, Inc.
Via Business Wire
Looking Into MEI Pharma's Return On Capital Employed
MEI Pharma (NASDAQ:MEIP) brought in sales totaling $11.41 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 84.1%, resulting in a loss of $16.06 million. 
Via Benzinga
MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
Earnings Scheduled For September 8, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second... 
Via Benzinga
Earnings Outlook For MEI Pharma
MEI Pharma (NASDAQ:MEIP) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that MEI Pharma will... 
Via Benzinga
MEI Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma to Release 2022 Fiscal Year End Financial Results and Provide Corporate Update on September 8, 2022
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From MEI Pharma, Inc.
Via Business Wire
Recap of Monday's Biotech Catalysts - End of the Day Summary
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least... 
Via Benzinga
MEI Pharma and Kyowa Kirin Announce Publication in The Lancet Oncology of Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancy
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From MEI Pharma, Inc.
Via Business Wire
Looking Into MEI Pharma's Return On Capital Employed
According to Benzinga Pro data, during Q3, MEI Pharma (NASDAQ:MEIP) posted sales of $9.69 million. Earnings were up 28.22%, but MEI Pharma still reported an overall loss of $8.72 million. 
Via Benzinga
MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma and Kyowa Kirin Report Clinical Data on Zandelisib at European Hematology Association 2022 Hybrid Congress
From MEI Pharma, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.